日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

miR-30a enhanced RIG-I-mediated type I interferon antiviral response by targeting USP14.

miR-30a 通过靶向 USP14 增强 RIG-I 介导的 I 型干扰素抗病毒反应

Zhang Jikai, Wang Yiwen, Sun Ningye, Zou Botao, Wang Zijie, Yin Hang, Xie Jiaqian, Xia Banruo, Sun Nan

TRIM56 enhances adenoviral E1A steady state to improve oncolytic adenovirus therapy efficacy.

TRIM56 增强腺病毒 E1A 的稳态,从而提高溶瘤腺病毒疗法的疗效

Sun Nan, Zhang Jikai, Zhang Chen, Yin Hang, Zou Botao, Geng Yunfeng, Gao Wanjun, Zhang Yuxin, Wang Gang, Zheng Junnian, Fang Lin

TRIM36 serves as a prognostic indicator linked to immune infiltration in KIRC

TRIM36 可作为肾透明细胞癌中免疫浸润相关的预后指标。

Zhang, Jikai; Zou, Botao; Geng, Yunfeng; Yin, Hang; Qin, Baoying; Gao, Wanjun; Lin, Xiaoman; Sun, Nan